Related Experiment Videos

Halothane does not alter Ca2+ affinity of troponin C

T J Blanck1, E Chiancone, G Salviati

  • 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.

Anesthesiology
|January 1, 1992
PubMed

Insights

Volatile anesthetics like halothane do not affect cardiac troponin C structure or its calcium binding. This suggests troponin C is not the target for halothane's negative inotropic effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Anesthesiology

Background:

  • Volatile anesthetics can induce negative inotropic effects.
  • Cardiac troponin C (cTnC) is a potential target for these effects.
  • Understanding anesthetic interactions with cTnC is crucial for cardiac function research.

Purpose of the Study:

  • To investigate the impact of halothane on the structure and Ca2+ binding of cardiac troponin C.
  • To assess the effect of halothane on the Ca2+-dependent force generation in muscle fibers.

Main Methods:

  • Measured intrinsic tyrosine fluorescence and UV circular dichroism of cTnC with varying Ca2+ concentrations in the presence and absence of halothane.
  • Assessed the binding rate of a sulfhydryl reagent to cTnC to evaluate low-affinity Ca2+ sites.
  • Determined the pCa/tension relationship in skinned soleus muscle fibers using halothane.

Main Results:

  • Halothane did not alter the Ca2+-induced fluorescence enhancement or the Ca2+ concentration for half-maximal effect in cTnC.
  • Secondary structure of cTnC, measured by molar ellipticity, showed similar increases with Ca2+ regardless of halothane presence.
  • Halothane did not affect the Ca2+ sensitivity or maximal tension in skinned soleus muscle fibers.

Conclusions:

  • Halothane does not appear to alter the structure or Ca2+ binding properties of cardiac troponin C.
  • The study provides evidence against troponin C being the primary molecular target for halothane's negative inotropic action.
  • Further research is needed to identify the specific molecular targets of volatile anesthetics in cardiac muscle.

Related Concept Videos